oral tirzepatide studies Safety and efficacy of as an add-on to single antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial Subcutaneously administered tirzepatide vs semaglutide
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31





:max_bytes(150000):strip_icc()/GettyImages-2260914806-2616be1382184e17a167d542d97230d7.jpg)

















